Physician profile
Thomas E Browning
NPI 1770617060
$1,090.84
in general payments reported to CMS, 2019-2025
12 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2023: $226 · 2024: $411 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $356.55 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $172.04 | 2023-2025 | |
| Abbott Laboratories | $145.70 | 2021-2025 | Freestyle Libre |
| Lilly USA, LLC | $87.85 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $60.41 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $59.52 | 2023-2024 | Farxiga, Airsupra |
| Exact Sciences Corporation | $57.86 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $42.01 | 2025 | Dexcom G6 Transmitter |
| Renalytix Ai, INC. | $39.11 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Sumitomo Pharma America, INC. | $28.13 | 2024 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.88 | 2025 | |
| Axsome Therapeutics, INC. | $14.78 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.